Related projects
Discover more projects across a range of sectors and discipline — from AI to cleantech to social innovation.
Schizophrenia is a devastating disease for which there is no cure. Available treatments aim at minimizing the symptoms. However, patients often stop taking their tablets, which leads to a worsening of their symptoms, referred to as relapse. In order to avoid the problems of discontinuation, some treatments are administered through an injection. Several studies have been conducted to compare the benefits of tablets versus injectable treatments on the risk of relapse. However, to combine those results is a challenge because relapse is not defined the same way across those studies. This project will be conducted to identify all the definitions of relapse that have been used and to determine whether combining the results is methodologically acceptable.
Grégoire Leclair
Tiffany Cristarella
Yola Rx Consultants
Pharmacy / Pharmacology
Manufacturing
Université de Montréal
Accelerate
Discover more projects across a range of sectors and discipline — from AI to cleantech to social innovation.
Find the perfect opportunity to put your academic skills and knowledge into practice!
Find ProjectsThe strong support from governments across Canada, international partners, universities, colleges, companies, and community organizations has enabled Mitacs to focus on the core idea that talent and partnerships power innovation — and innovation creates a better future.